“Ruxolitinib Cream is Associated With Reduced Treatment Burden in Atopic Dermatitis: A US Payer Claim Analysis”, J of Skin, vol. 9, no. 6, p. s591, Nov. 2025, doi: 10.25251/9yfem502.